BRAIN Biotech AG

XTRA:BNN Rapporto sulle azioni

Cap. di mercato: €37.7m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

BRAIN Biotech Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Aryan Moelker

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO4.5yrs
Proprietà del CEOn/a
Durata media del management2.8yrs
Durata media del Consiglio di amministrazione3.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

BRAIN Biotech AG (ETR:BNN) Screens Well But There Might Be A Catch

Aug 06
BRAIN Biotech AG (ETR:BNN) Screens Well But There Might Be A Catch

Is BRAIN Biotech (ETR:BNN) Weighed On By Its Debt Load?

Jun 29
Is BRAIN Biotech (ETR:BNN) Weighed On By Its Debt Load?

BRAIN Biotech AG (ETR:BNN) Shares Could Be 36% Below Their Intrinsic Value Estimate

Apr 19
BRAIN Biotech AG (ETR:BNN) Shares Could Be 36% Below Their Intrinsic Value Estimate

BRAIN Biotech AG's (ETR:BNN) P/S Still Appears To Be Reasonable

Mar 28
BRAIN Biotech AG's (ETR:BNN) P/S Still Appears To Be Reasonable

Is BRAIN Biotech (ETR:BNN) A Risky Investment?

Feb 16
Is BRAIN Biotech (ETR:BNN) A Risky Investment?

Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt

Sep 13
Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt

Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like

Mar 21
Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like

Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?

Feb 14
Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?

When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?

Jan 18
When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?

How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?

Dec 31
How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?

Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?

Dec 10
Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?

Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?

Nov 17
Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Aryan Moelker rispetto agli utili di BRAIN Biotech?
DataCompenso totaleStipendioGuadagni aziendali
Mar 31 2024n/an/a

-€8m

Dec 31 2023n/an/a

-€8m

Sep 30 2023n/an/a

-€8m

Jun 30 2023n/an/a

-€7m

Mar 31 2023n/an/a

-€7m

Dec 31 2022n/an/a

-€7m

Sep 30 2022n/an/a

-€7m

Jun 30 2022n/an/a

-€8m

Mar 31 2022n/an/a

-€8m

Dec 31 2021n/an/a

-€4m

Sep 30 2021€957k€420k

-€5m

Jun 30 2021n/an/a

-€6m

Mar 31 2021n/an/a

-€6m

Dec 31 2020n/an/a

-€11m

Sep 30 2020€885k€280k

-€10m

Compensazione vs Mercato: Dati insufficienti per stabilire se la retribuzione totale di Aryan sia ragionevole rispetto ad aziende di dimensioni simili nel mercato German.

Compensazione vs guadagni: La retribuzione di Aryan è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Aryan Moelker

4.5yrs

Mandato

€957,000

Compensazione

Mr. Adriaan Moelker, also known as Aryan, serves as Director of SolasCure Limited. He has been Chairman of the Management Board and Chief Executive Officer of BRAIN Biotech AG (formerly known as B.R.A.I.N....

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Adriaan Moelker
Chairman of the Management Board & CEO4.5yrs€957.00kNessun dato
Ulrich Putsch
Co-Founderno dataNessun datoNessun dato
Michael Schneiders
CFO & Member of Management Board1.8yrsNessun datoNessun dato
Ute Dechert
Vice President of Human Resources & Processes3.8yrsNessun datoNessun dato
Jurgen Eck
Consultant4.7yrs€392.00kNessun dato
Martin Langer
MD & Executive VPno dataNessun datoNessun dato
Alexander Pelzer
VP and Head of Research & Development - Zwingenberg1.6yrsNessun datoNessun dato
Robbert Hoekstra
Head of Group Finance1.8yrsNessun datoNessun dato
Paul Scholz
Technical Lead of Genome Editing Developmentno dataNessun datoNessun dato

2.8yrs

Durata media

56.5yo

Età media

Gestione esperta: Il team dirigenziale di BNN è considerato esperto (durata media dell'incarico 2.8 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Wiltrud Treffenfeldt
Independent Member of Supervisory Board3.8yrs€28.00kNessun dato
Stephen Catling
Independent Member of Supervisory Board3.8yrs€31.00kNessun dato
Michael Majerus
Independent Chairman of the Supervisory Board5.4yrs€51.00kNessun dato
Anna Eichhorn
Vice Chairwoman of the Supervisory Board7.4yrs€53.00kNessun dato
Christine Uekert
Independent Supervisory Board Member1.4yrsNessun datoNessun dato
Florian Schnabel
Supervisory Board Member1.4yrsNessun datoNessun dato

3.8yrs

Durata media

57yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di BNN sono considerati esperti (durata media dell'incarico 3.8 anni).